Streptozotocin-induced diabetes selectively enhances antinociception mediated by δ1-but not δ2-opioid receptors

Autor: Yutaka Kasuya, Junzo Kamei, Hiroshi Nagase, Miwa Misawa, Yuriko Iwamoto
Rok vydání: 1994
Předmět:
Zdroj: Life Sciences. 55:PL121-PL126
ISSN: 0024-3205
DOI: 10.1016/0024-3205(94)90062-0
Popis: We assessed the effect of diabetes on antinociception produced by intracerebroventricular injection of δ-opioid receptor agonists [D-Pen 2,5 ]enkephalin (DPDPE) and [D-Ala 2 ]deltorphin II. The antinociceptive effect of DPDPE (10 nmol), administered i.c.v., was significantly greater in diabetic mice than in non-diabetic mice. The antinociceptive effect of i.c.v. DPDPE was significantly reduced in both diabetic and non-diabetic mice following pretreatment with 7-benzylidenenaltrexone (BNTX), a selective δ 1 -opioid receptor antagonist, but not with naltriben (NTB), a selective δ 2 - opioid receptor antagonist. There were no significant differences in the anticiceptive effect of [D-Ala 2 ]deltorphin II (3 nmol, i.c.v.) in diabetic and non-diabetic mice. Furthermore, the antinociceptive effect of i.c.v. [D-Ala 2 ]deltorphin II was significantly reduced in both diabetic and non-diabetic mice following pretreatment with NTB, but not with BNTX. In conclusion, mice with diabetes are selectively hyper-responsive to supraspinal δ 1 -opioid receptor-mediated antinociception, but are normally responsive to activation of δ 2 -opiod receptors.
Databáze: OpenAIRE